药学与临床研究2024,Vol.32Issue(6) :562-565.

已上市化学药品注射剂变更生产批量技术要求、研究思路和常见问题分析

Analysis of Technical Requirements,Research Strategies and Typical Prob-lems of Batch Size Change in Post-approval Chemical Drug Injections

华苏 潘文 孙骏
药学与临床研究2024,Vol.32Issue(6) :562-565.

已上市化学药品注射剂变更生产批量技术要求、研究思路和常见问题分析

Analysis of Technical Requirements,Research Strategies and Typical Prob-lems of Batch Size Change in Post-approval Chemical Drug Injections

华苏 1潘文 1孙骏1
扫码查看

作者信息

  • 1. 江苏省药品监督管理局审评中心,南京 210002
  • 折叠

摘要

本文在梳理已上市化学药品注射剂生产批量变更相关指导原则及技术要求的基础上,从关联变更、工艺验证、质量对比研究等方面阐述变更的研究思路,结合药品上市后注册管理事项中等变更日常审查工作实践,总结变更管理中的变更信息描述不全、验证不符合相关指导原则要求、质量对比不全面、稳定性研究不规范等常见问题.

Abstract

Based on reviewing the guidance and technical requirements for batch size changes in pro-duction of marketed chemical drug injections,this article elaborates on the research ideas of changes in aspects such as related changes,process validation and quality comparative studies.Combining with the re-view of post-market registration management matters for changes in daily practice,this article summarizes some common issues in change management,such as incomplete description of change information,failure to comply with relevant guidance for validation,lack of comprehensive quality comparison and non-stan-dardized stability research.

关键词

化学药品/注射剂/变更/批量/研究思路

Key words

Chemicals Drug/Injection/Changes/Batch/Research approach

引用本文复制引用

出版年

2024
药学与临床研究
江苏省药学会

药学与临床研究

CSTPCD
影响因子:0.95
ISSN:1673-7806
段落导航相关论文